Squadron Capital committed to provide an additional US $30MM in secured debt financing to Alphatec, beyond the $35 million provided in 4Q18. Proceeds will support the company as it seeks to scale up to $200MM in annual revenue by 2022.
Thus far in 2019, Alphatec has announced FDA 510(k) clearance to market automated SafeOp neuromonitoring for real-time intra-op nerve location, and launched the IdentiTi-C Porous Titanium Interbody for anterior cervical discectomy and fusion. The latter is the first of six IdentiTi titanium systems that the company intends to introduce this year.
Squadron Capital serves the orthopedic industry with capital and manufacturing resources in four plants located in Alabama, Connecticut, Florida and North Carolina, offering a “hybrid” support model of integrated product financing and manufacturing to OEM customers.
Source: Squadron Capital
Squadron Capital committed to provide an additional US $30MM in secured debt financing to Alphatec, beyond the $35 million provided in 4Q18. Proceeds will support the company as it seeks to scale up to $200MM in annual revenue by 2022.
Thus far in 2019, Alphatec has announced FDA 510(k) clearance to market automated SafeOp neuromonitoring...
Squadron Capital committed to provide an additional US $30MM in secured debt financing to Alphatec, beyond the $35 million provided in 4Q18. Proceeds will support the company as it seeks to scale up to $200MM in annual revenue by 2022.
Thus far in 2019, Alphatec has announced FDA 510(k) clearance to market automated SafeOp neuromonitoring for real-time intra-op nerve location, and launched the IdentiTi-C Porous Titanium Interbody for anterior cervical discectomy and fusion. The latter is the first of six IdentiTi titanium systems that the company intends to introduce this year.
Squadron Capital serves the orthopedic industry with capital and manufacturing resources in four plants located in Alabama, Connecticut, Florida and North Carolina, offering a “hybrid” support model of integrated product financing and manufacturing to OEM customers.
Source: Squadron Capital
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.